Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping

Christopher Jon Klein, Vanda A Lennon, Paula A. Aston, Andrew B McKeon, Orna O'Toole, Amy Quek, Sean J Pittock

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Objective: To determine, in patients identified as seropositive for neuronal voltage-gated potassium channel (VGKC) complex autoantibodies, the spectrum of clinical presentations and frequency of leucine-rich gliomainactivated protein 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) as defined antigenic neuronal targets in the VGKC macromolecular complex. Design: Retrospective cohort study. Setting: Clinical practice, Mayo Clinic Neuroimmunology Laboratory and Department of Neurology. Patients: A total of 54 853 patients were evaluated, of whom 1992 were found to be VGKC complex IgG positive. Results: From June 1,2008, to June 30,2010, comprehensive service serologic evaluation performed on 54 853 patients with unexplained neurologic symptoms identified 1992 patients (4%) who were positive for VGKC complex IgG (values ≥ 0.03 nmol/L). Among 316 seropositive patients evaluated clinically at our institution, 82 (26%) were seropositive for LGI1 IgG and/or CASPR2 IgG. Of these 82 patients, 27% had low (0.03-0.09 nmol/L), 51% had medium (0.10-0.99 nmol/L), and 22% had high (≥ 1.00 nmol/L) VGKC complex IgG values. Leucine-rich glioma-inactivated protein 1 IgG positivity was associated with higher VGKC complex IgG values (P <.001) and cortical presentations (P <.001); CASPR2 IgG was associated with peripheral motor excitability (P= .009). However, neither autoantibody was pathognomonic for a specific neurologic presentation or correlated significantly with cancer. Neurologic phenotypes were diverse. Cerebrocortical manifestations (including cognitive impairment and seizures) were recorded in 76% of patients with LGI1 IgG alone (n=46) and 29% with CASPR2 IgG alone (n=28). Peripheral motor hyperexcitability was found in 21% of patients with CASPR2 IgG alone and 6.5% of patients with LGI1 IgG alone. Conclusions: The study emphasizes diverse and overlapping neurologic phenotypes across a range of VGKC complex IgG values and varying LGI1 IgG and CASPR2 IgG specificities. The frequent occurrence of LGI1 IgG and CASPR2 IgG in serum samples with low and medium VGKC complex IgG values supports the clinical significance of low values in clinical evaluation. Additional antigenic components of VGKC macromolecular complexes remain to be defined.

Original languageEnglish (US)
Pages (from-to)229-234
Number of pages6
JournalJAMA Neurology
Volume70
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Contactin 1
Potassium Channels
Leucine
Autoantibodies
Immunoglobulin G
Proteins
Contactins
Nervous System
Macromolecular Substances
Protein

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. / Klein, Christopher Jon; Lennon, Vanda A; Aston, Paula A.; McKeon, Andrew B; O'Toole, Orna; Quek, Amy; Pittock, Sean J.

In: JAMA Neurology, Vol. 70, No. 2, 02.2013, p. 229-234.

Research output: Contribution to journalArticle

@article{78e5dbf0fe1641ab8aafec9def53898e,
title = "Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping",
abstract = "Objective: To determine, in patients identified as seropositive for neuronal voltage-gated potassium channel (VGKC) complex autoantibodies, the spectrum of clinical presentations and frequency of leucine-rich gliomainactivated protein 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) as defined antigenic neuronal targets in the VGKC macromolecular complex. Design: Retrospective cohort study. Setting: Clinical practice, Mayo Clinic Neuroimmunology Laboratory and Department of Neurology. Patients: A total of 54 853 patients were evaluated, of whom 1992 were found to be VGKC complex IgG positive. Results: From June 1,2008, to June 30,2010, comprehensive service serologic evaluation performed on 54 853 patients with unexplained neurologic symptoms identified 1992 patients (4{\%}) who were positive for VGKC complex IgG (values ≥ 0.03 nmol/L). Among 316 seropositive patients evaluated clinically at our institution, 82 (26{\%}) were seropositive for LGI1 IgG and/or CASPR2 IgG. Of these 82 patients, 27{\%} had low (0.03-0.09 nmol/L), 51{\%} had medium (0.10-0.99 nmol/L), and 22{\%} had high (≥ 1.00 nmol/L) VGKC complex IgG values. Leucine-rich glioma-inactivated protein 1 IgG positivity was associated with higher VGKC complex IgG values (P <.001) and cortical presentations (P <.001); CASPR2 IgG was associated with peripheral motor excitability (P= .009). However, neither autoantibody was pathognomonic for a specific neurologic presentation or correlated significantly with cancer. Neurologic phenotypes were diverse. Cerebrocortical manifestations (including cognitive impairment and seizures) were recorded in 76{\%} of patients with LGI1 IgG alone (n=46) and 29{\%} with CASPR2 IgG alone (n=28). Peripheral motor hyperexcitability was found in 21{\%} of patients with CASPR2 IgG alone and 6.5{\%} of patients with LGI1 IgG alone. Conclusions: The study emphasizes diverse and overlapping neurologic phenotypes across a range of VGKC complex IgG values and varying LGI1 IgG and CASPR2 IgG specificities. The frequent occurrence of LGI1 IgG and CASPR2 IgG in serum samples with low and medium VGKC complex IgG values supports the clinical significance of low values in clinical evaluation. Additional antigenic components of VGKC macromolecular complexes remain to be defined.",
author = "Klein, {Christopher Jon} and Lennon, {Vanda A} and Aston, {Paula A.} and McKeon, {Andrew B} and Orna O'Toole and Amy Quek and Pittock, {Sean J}",
year = "2013",
month = "2",
doi = "10.1001/jamaneurol.2013.592",
language = "English (US)",
volume = "70",
pages = "229--234",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping

AU - Klein, Christopher Jon

AU - Lennon, Vanda A

AU - Aston, Paula A.

AU - McKeon, Andrew B

AU - O'Toole, Orna

AU - Quek, Amy

AU - Pittock, Sean J

PY - 2013/2

Y1 - 2013/2

N2 - Objective: To determine, in patients identified as seropositive for neuronal voltage-gated potassium channel (VGKC) complex autoantibodies, the spectrum of clinical presentations and frequency of leucine-rich gliomainactivated protein 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) as defined antigenic neuronal targets in the VGKC macromolecular complex. Design: Retrospective cohort study. Setting: Clinical practice, Mayo Clinic Neuroimmunology Laboratory and Department of Neurology. Patients: A total of 54 853 patients were evaluated, of whom 1992 were found to be VGKC complex IgG positive. Results: From June 1,2008, to June 30,2010, comprehensive service serologic evaluation performed on 54 853 patients with unexplained neurologic symptoms identified 1992 patients (4%) who were positive for VGKC complex IgG (values ≥ 0.03 nmol/L). Among 316 seropositive patients evaluated clinically at our institution, 82 (26%) were seropositive for LGI1 IgG and/or CASPR2 IgG. Of these 82 patients, 27% had low (0.03-0.09 nmol/L), 51% had medium (0.10-0.99 nmol/L), and 22% had high (≥ 1.00 nmol/L) VGKC complex IgG values. Leucine-rich glioma-inactivated protein 1 IgG positivity was associated with higher VGKC complex IgG values (P <.001) and cortical presentations (P <.001); CASPR2 IgG was associated with peripheral motor excitability (P= .009). However, neither autoantibody was pathognomonic for a specific neurologic presentation or correlated significantly with cancer. Neurologic phenotypes were diverse. Cerebrocortical manifestations (including cognitive impairment and seizures) were recorded in 76% of patients with LGI1 IgG alone (n=46) and 29% with CASPR2 IgG alone (n=28). Peripheral motor hyperexcitability was found in 21% of patients with CASPR2 IgG alone and 6.5% of patients with LGI1 IgG alone. Conclusions: The study emphasizes diverse and overlapping neurologic phenotypes across a range of VGKC complex IgG values and varying LGI1 IgG and CASPR2 IgG specificities. The frequent occurrence of LGI1 IgG and CASPR2 IgG in serum samples with low and medium VGKC complex IgG values supports the clinical significance of low values in clinical evaluation. Additional antigenic components of VGKC macromolecular complexes remain to be defined.

AB - Objective: To determine, in patients identified as seropositive for neuronal voltage-gated potassium channel (VGKC) complex autoantibodies, the spectrum of clinical presentations and frequency of leucine-rich gliomainactivated protein 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) as defined antigenic neuronal targets in the VGKC macromolecular complex. Design: Retrospective cohort study. Setting: Clinical practice, Mayo Clinic Neuroimmunology Laboratory and Department of Neurology. Patients: A total of 54 853 patients were evaluated, of whom 1992 were found to be VGKC complex IgG positive. Results: From June 1,2008, to June 30,2010, comprehensive service serologic evaluation performed on 54 853 patients with unexplained neurologic symptoms identified 1992 patients (4%) who were positive for VGKC complex IgG (values ≥ 0.03 nmol/L). Among 316 seropositive patients evaluated clinically at our institution, 82 (26%) were seropositive for LGI1 IgG and/or CASPR2 IgG. Of these 82 patients, 27% had low (0.03-0.09 nmol/L), 51% had medium (0.10-0.99 nmol/L), and 22% had high (≥ 1.00 nmol/L) VGKC complex IgG values. Leucine-rich glioma-inactivated protein 1 IgG positivity was associated with higher VGKC complex IgG values (P <.001) and cortical presentations (P <.001); CASPR2 IgG was associated with peripheral motor excitability (P= .009). However, neither autoantibody was pathognomonic for a specific neurologic presentation or correlated significantly with cancer. Neurologic phenotypes were diverse. Cerebrocortical manifestations (including cognitive impairment and seizures) were recorded in 76% of patients with LGI1 IgG alone (n=46) and 29% with CASPR2 IgG alone (n=28). Peripheral motor hyperexcitability was found in 21% of patients with CASPR2 IgG alone and 6.5% of patients with LGI1 IgG alone. Conclusions: The study emphasizes diverse and overlapping neurologic phenotypes across a range of VGKC complex IgG values and varying LGI1 IgG and CASPR2 IgG specificities. The frequent occurrence of LGI1 IgG and CASPR2 IgG in serum samples with low and medium VGKC complex IgG values supports the clinical significance of low values in clinical evaluation. Additional antigenic components of VGKC macromolecular complexes remain to be defined.

UR - http://www.scopus.com/inward/record.url?scp=84874028922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874028922&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2013.592

DO - 10.1001/jamaneurol.2013.592

M3 - Article

C2 - 23407760

AN - SCOPUS:84874028922

VL - 70

SP - 229

EP - 234

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 2

ER -